METALYSE Boehringer Ingelheim Pty Ltd
Product name
METALYSE
Sponsor
Accepted date
Apr-2024
Active ingredients
Tenecteplase
Proposed indication
Indicated in adults for the treatment of acute ischaemic stroke after exclusion of intracranial haemorrhage.
Application type
C (new medicine)
Publication date
Apr-2024